Clinical Trials Directory

Trials / Completed

CompletedNCT03884777

Incidence and Risk of Influenza in Myasthenic Patients

Incidence and Risk of Influenza in Myasthenic Patients Hospitalized in Intensive Care

Status
Completed
Phase
Study type
Observational
Enrollment
400 (actual)
Sponsor
Centre d'Investigation Clinique et Technologique 805 · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Upper respiratory infection , including influenza, may exacerbate the symptoms of myasthenia gravis (MG), which is an autoimmune disease that causes muscle weakness and, in some cases, can precipitate a myasthenic crisis In the present study, we investigated the incidence and risk factors of influenza infection on in myasthenia gravis patients.

Detailed description

This is a descriptive study. The data will be analyzed retrospectively . Inclusion of 416 cases of influenza in myasthenic patients treated in the intensive care unit of Garches Hospital between January 1, 2009 and December 31, 2017. Patients who meet the inclusion and non inclusion criteria and do not object to participate in the study will be collected in a database for analysis.

Conditions

Timeline

Start date
2009-01-01
Primary completion
2017-12-31
Completion
2017-12-31
First posted
2019-03-21
Last updated
2019-03-21

Source: ClinicalTrials.gov record NCT03884777. Inclusion in this directory is not an endorsement.